Clinical Trials Logo

Phobic Disorders clinical trials

View clinical trials related to Phobic Disorders.

Filter by:

NCT ID: NCT00121069 Completed - Phobic Disorders Clinical Trials

Study of Escitalopram in the Treatment of Specific Phobia

Start date: September 2002
Phase: Phase 2/Phase 3
Study type: Interventional

This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients.

NCT ID: NCT00118833 Completed - Anxiety Disorders Clinical Trials

St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)

Start date: August 2002
Phase: Phase 2/Phase 3
Study type: Interventional

This study will determine whether the herbal product St. John's wort is safe and effective in treating generalized social anxiety disorder (GSAD). Study hypothesis: Hypericum perforatum (St. John's wort) is more effective in treating GSAD than placebo.

NCT ID: NCT00114127 Completed - Anxiety Disorder Clinical Trials

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Start date: June 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the safety and efficacy of duloxetine for the treatment of social anxiety disorder.

NCT ID: NCT00104195 Completed - Anxiety Disorders Clinical Trials

A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions

Start date: February 2004
Phase: Phase 1
Study type: Observational

The purpose of this trial is to study how teens with and without an anxiety disorder make decisions. This is a brain imaging study using functional magnetic resonance imaging (fMRI) in adolescents between the ages of 13 and 17.

NCT ID: NCT00074802 Completed - Clinical trials for Social Anxiety Disorder

Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder

Start date: December 2003
Phase: Phase 3
Study type: Interventional

This study will determine whether the addition of cognitive behavioral therapy can improve the effectiveness of the medication paroxetine (Paxil®) in treating individuals with social anxiety disorder.

NCT ID: NCT00073333 Completed - Social Phobia Clinical Trials

Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia

Start date: December 2002
Phase: N/A
Study type: Interventional

This study will determine whether people with social phobia are deficient in certain social skills.

NCT ID: NCT00062517 Completed - Anxiety Disorders Clinical Trials

Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning

Start date: June 5, 2003
Phase: N/A
Study type: Observational

The purpose of this study is to increase researchers understanding of the biological basis of generalized anxiety disorder and social anxiety disorder. They will investigate how the brain activity associated with specific thoughts and feelings may play a role in these anxiety disorders. This knowledge will be used to design interventions to help those with these illnesses. To qualify for this study, participants must be evaluated via an initial telephone screening interview and material sent through the mail. Participants will then be required to make three visits to NIH. During the first visit, they will be asked questions about their general mood, degree of nervousness, thinking skills, and behavior. They will undergo a thorough physical exam, including an EKG, blood work, urinalysis, and a pregnancy test for women of childbearing potential. During the second visit, participants will spend about 2.5 hours doing various tasks while sitting and looking at a computer screen. These tasks will guide them to experience specific kinds of thoughts and emotions. Researchers will attach electrodes to the participants hands to monitor the amount of electricity conducted by the skin. The third visit will be similar to the second visit, but participants will perform the tasks while lying in a MRI scanner. Participants will be compensated up to $400 for their involvement in this study.

NCT ID: NCT00052078 Completed - Anxiety Disorders Clinical Trials

Child and Adolescent Anxiety Disorders (CAMS)

Start date: January 2003
Phase: Phase 3
Study type: Interventional

This randomized, controlled trial compared the efficacy of the medication sertraline (Zoloft®), cognitive-behavioral therapy, the combination of these treatments, and placebo for youth with anxiety disorders.

NCT ID: NCT00051220 Completed - Anxiety Disorders Clinical Trials

Treatment for Specific Phobias in Children

Start date: October 2001
Phase: Phase 1/Phase 2
Study type: Interventional

This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.

NCT ID: NCT00043537 Completed - Social Phobia Clinical Trials

Treatment of Childhood Social Phobia

Start date: April 2001
Phase: Phase 3
Study type: Interventional

This 4-year study will compare the long-term effectiveness of behavioral treatment, fluoxetine (Prozac®), and placebo for treatment of social phobia in children and adolescents.